EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

How Physiology and Pharmacology Shape Liver Regeneration: From Molecules and Cells to Trials

Amedeo Lonardo iD, Ralf Weiskirchen iD

International Journal of Molecular Sciences · 03.07.2026 · 27 (13) · 5967

DOI: 10.3390/ijms27135967 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.07.2026. Verfasst von Amedeo Lonardo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher, 41100 Modena, Italy. Hauptthemen laut MEDLINE: Liver Regeneration, Liver, Liver Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver regeneration is a tightly orchestrated compensatory response in which the remaining liver regains mass and function after liver injury or surgical resection. However, it does not fully restore its original anatomy. This process involves sequential priming, proliferative, and termination phases that are controlled by inflammatory cytokines, growth factor signaling, metabolic regulation, and extracellular matrix remodeling. Clinically, regenerative capacity plays a crucial role in situations such as partial hepatectomy, acute liver failure, and chronic liver disease. Unfortunately, it can be compromised by conditions like cirrhosis, steatosis, diabetes, and other systemic or local disorders. Current strategies to improve regeneration, such as portal vein modulation, cell-based therapies, organoid technology, and bioartificial liver support, show promise. However, they are limited by challenges including impaired engraftment, functional immaturity, technical complexity, and scalability restrictions. Against this background, the present review explores the pathophysiological basis of liver regeneration and evaluates the clinical evidence on nutritional and pharmacological interventions aimed at enhancing the natural liver repair mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver RegenerationLiverLiver DiseasesHumansAnimalsClinical Trials as TopicSignal Transduction

Stichwörter der Autor:innen

clinical trialsliver regenerationmolecular physiologypharmacology

Autor:innen und Institutionen

  • Independent Researcher, 41100 Modena, Italy.
  • Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aachen, Germany.

ORCID-Profile: Amedeo Lonardo, Ralf Weiskirchen

Zitieren

APA

Lonardo, A., & Weiskirchen, R. (2026). How Physiology and Pharmacology Shape Liver Regeneration: From Molecules and Cells to Trials. International Journal of Molecular Sciences, 27(13), 5967. https://doi.org/10.3390/ijms27135967

Vancouver

Lonardo A, Weiskirchen R. How Physiology and Pharmacology Shape Liver Regeneration: From Molecules and Cells to Trials. International Journal of Molecular Sciences. 2026;27(13):5967. doi:10.3390/ijms27135967

BibTeX
@article{Lonardo2026,
  author = {Lonardo, Amedeo and Weiskirchen, Ralf},
  title = {How Physiology and Pharmacology Shape Liver Regeneration: From Molecules and Cells to Trials},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {5967},
  doi = {10.3390/ijms27135967}
}
Kostenlos starten →